Amgen soars after bagging Onyx Pharma in $ buyout deal #mcneil #pharma

Posted On Jun 11 2017 by

#onyx pharma # Amgen soars after bagging Onyx Pharma in $10.4B buyout deal Amgen was the first company to make it to the auction block for Onyx Pharmaceuticals. And in the end, it was the only serious bidder at the table. After starting out with an unsolicited $120-a-share offer for Onyx ($ONXX), the giant biopharma company settled on a final price of $125 a share–all of it to be paid in cash–valuing Onyx at $10.4 billion, or $9.7 billion net of cash. News of the impending buyout had been percolating all weekend long after The New York Times first reported …


PharmaSmart – and Giant Eagle Supermarkets Ink Major Deal #biotech #pharma #jobs

Posted On Jun 10 2017 by

#www.pharma-smart.com # PharmaSmart and Giant Eagle Supermarkets Ink Major Deal We agree with the CDC, which recently announced that controlling blood pressure is the single most important thing Americans can do to improve their health outcomes. Rochester, NY (PRWEB) August 08, 2016 PharmaSmart International Inc. a prominent Rochester, NY manufacturer of health screening kiosks, and developer of Health IT and health management solutions, announces their partnership with Giant Eagle Supermarkets. PharmaSmart will deploy its clinically validated blood pressure Kiosk and cloud based Health IT platform across 217 Giant Eagle Supermarkets. This includes Giant Eagle, Market District, and Market District Express …


Pharma Services deal seals MDS exit from contract research #mankind #pharma

Posted On May 19 2017 by

#mds pharma services # Pharma Services deal seals MDS exit from contract research Canadian life sciences company MDS has found buyers for the rest of its MDS Pharma Services unit, rounding off its exit strategy for the contract research sector. MDS will divest the remaining Early Stage components of its US-based contract research organisation (CRO) to Ricerca Biosciences and private investors for US$45 million as well as a minority interest in a new corporation being set up for the transaction. The deal, which is expected to close within two months, does not include MDS Pharma Services’ Early Stage Development facility …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell

Posted On May 19 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


URL Pharma – s $800 million deal is all about gout #elite #pharma

Posted On May 14 2017 by

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …


Pharma Services deal seals MDS exit from contract research #generic #pharma #companies

Posted On Apr 24 2017 by

#mds pharma services # Pharma Services deal seals MDS exit from contract research Canadian life sciences company MDS has found buyers for the rest of its MDS Pharma Services unit, rounding off its exit strategy for the contract research sector. MDS will divest the remaining Early Stage components of its US-based contract research organisation (CRO) to Ricerca Biosciences and private investors for US$45 million as well as a minority interest in a new corporation being set up for the transaction. The deal, which is expected to close within two months, does not include MDS Pharma Services’ Early Stage Development facility …


Seamus Mulligan s Azur to merge with US pharma firm in $500m deal – Rockwell

Posted On Apr 23 2017 by

#azur pharma # Seamus Mulligan’s Azur to merge with US pharma firm in $500m deal Sunday, 16th October 2011 IRISH PHARMA group Azur, which is led by former Elan executive Séamus Mulligan (1977), has agreed to merge with Nasdaq-listed Jazz Pharmaceuticals in a deal that values the Dublin-based company at $500 million (365.5 million). Seamus was the 2005 Union Business Lunch guest speaker. This is an all-share transaction that will give Azurs shareholders just over 20 per cent of the combined entity. Jazzs owners will hold the balance. The deal, which was announced in California on Monday, is subject to …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cmc #pharma

Posted On Apr 23 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


URL Pharma – s $800 million deal is all about gout #lilly #pharma

Posted On Apr 19 2017 by

#url pharma # URL Pharma s $800 million deal is all about gout Mike Armstrong Some think this is the classic Philadelphia story: Club boxer gets his shot at the heavyweight title and shocks the world. To me, the classic Philadelphia story is: Businessman starts a company. Son takes over and sends it to new heights. No, I m not referring to Comcast Corp. founded in 1963 by Ralph J. Roberts and now led by his son, Brian L. Roberts, who oversaw the transactions that turned it into a media giant. Today, I m talking about a different Roberts family, …


Amgen soars after bagging Onyx Pharma in $ buyout deal #euro #pharma

Posted On Apr 8 2017 by

#onyx pharma # Amgen soars after bagging Onyx Pharma in $10.4B buyout deal Amgen was the first company to make it to the auction block for Onyx Pharmaceuticals. And in the end, it was the only serious bidder at the table. After starting out with an unsolicited $120-a-share offer for Onyx ($ONXX), the giant biopharma company settled on a final price of $125 a share–all of it to be paid in cash–valuing Onyx at $10.4 billion, or $9.7 billion net of cash. News of the impending buyout had been percolating all weekend long after The New York Times first reported …